Will a senolytic therapy be approved for commercial sale by the US FDA before January 1, 2030?

Metaculus
★★★☆☆
59%
About Even
Yes

Question description

In recent years, a number of ventures have begun work on translating the results of some promising laboratory studies on senolytic agents into medicine for humans.

A senolytic agent is an agent introduced to the body for the purpose of selectively eliminating senescent cells from the patient. Senescent cells are cells in the body that no longer divide, having reached their Hayflick limit, but which do not automatically apoptose.

These senescent cells linger in the body triggering inflammatory responses, reducing the effectiveness of the immune system, and they are associated with many age-related diseases including type 2 diabetes and atherosclerosis which present a high disease and mortality burden, especially in the most-developed countries in which age-related diseases constitute the overwhelming majority of causes of death among populations.

Senescent cells are thought to play an important part in the aging process, and thus it is theorised that selectively removing these senescent cells would significantly improve healthspan (and perhaps, alone or as part of a combinatorial therapy, significantly extend lifespan).

One major player in this quickly developing area of medicine is Unity Biotechnology. Its pipeline includes several drugs currently in the lead optimization phase, with UBX0101 having this year entered Phase 1 of a randomized, double-blind, placebo-controlled, FDA-approved clinical trial.

You can find out more about these first trials, and more about senolytics in general, here.

Indicators

IndicatorValue
Stars
★★★☆☆
PlatformMetaculus
Number of forecasts384

Capture

Resizable preview:
59%
About Even

In recent years, a number of ventures have begun work on translating the results of some promising laboratory studies on senolytic agents into medicine for humans.

A senolytic agent is an agent introduced to the body for the purpose of selectively...

Last updated: 2024-04-18
★★★☆☆
Metaculus
Forecasts: 384

Embed

<iframe src="https://https://metaforecast.org/questions/embed/metaculus-1621" height="600" width="600" frameborder="0" />